| 1 |
35443346 | Role of Ambulatory Glucose Profile in Precision Medicine in Type 2 Diabetes Mellitus. | 2022 Apr |
1 |
| 2 |
35466084 | Identification of a novel hepatocyte nuclear factor-1 alpha (HNF1A) variant in maturity onset diabetes of the young type 3 (HNF1A-MODY). | 2022 Apr 1 |
1 |
| 3 |
35512857 | Effects of 1,5-anhydro-D-glucitol on insulin secretion both in in vitro and ex vivo pancreatic preparations. | 2022 Jun |
1 |
| 4 |
32594655 | Relationships between time in range, glycemic variability including hypoglycemia and types of diabetes therapy in Japanese patients with type 2 diabetes mellitus: Hyogo Diabetes Hypoglycemia Cognition Complications study. | 2021 Feb |
1 |
| 5 |
33464705 | An adult patient with permanent neonatal diabetes successfully discontinued insulin therapy after initiating sitagliptin added to sulphonylurea. | 2021 May |
1 |
| 6 |
33832649 | Molecular mechanisms of β-cell dysfunction and death in monogenic forms of diabetes. | 2021 |
1 |
| 7 |
34083248 | Risk factors for adverse outcomes among 35 879 veterans with and without diabetes after diagnosis with COVID-19. | 2021 Jun |
1 |
| 8 |
34099169 | Production and purification of ATP-sensitive potassium channel particles for cryo-electron microscopy. | 2021 |
1 |
| 9 |
34254494 | Neonatal diabetes mellitus due to a new KCNJ11 mutation - 10 years of the patient`s follow-up. | 2021 |
1 |
| 10 |
34539410 | Sulfonylureas for Treatment of Periodontitis-Diabetes Comorbidity-Related Complications: Killing Two Birds With One Stone. | 2021 |
1 |
| 11 |
34566892 | Molecular Genetics, Clinical Characteristics, and Treatment Outcomes of KATP-Channel Neonatal Diabetes Mellitus in Vietnam National Children's Hospital. | 2021 |
4 |
| 12 |
34726745 | Deintensification of Treatment With Sulfonylurea and Insulin After Severe Hypoglycemia Among Older Adults With Diabetes. | 2021 Nov 1 |
2 |
| 13 |
34748819 | Targeting the insulin granule for modulation of insulin exocytosis. | 2021 Dec |
1 |
| 14 |
34825567 | Photo-Switchable Sulfonylureas Binding to ATP-Sensitive Potassium Channel Reveal the Mechanism of Light-Controlled Insulin Release. | 2021 Dec 9 |
1 |
| 15 |
30213710 | Association of treatment-achieved HbA1c with incidence of coronary artery disease and severe eye disease in diabetes patients. | 2020 Sep |
1 |
| 16 |
31390154 | Neonatal diabetes caused by the heterozygous Pro1198Leu mutation in the ABCC8 gene in a male infant: 6-year clinical course. | 2020 Mar |
1 |
| 17 |
31562829 | Phenotype, genotype and glycaemic variability in people with activating mutations in the ABCC8 gene: response to appropriate therapy. | 2020 May |
1 |
| 18 |
31566370 | Structural Insights into the Inhibitory Mechanism of Insulin Secretagogues on the Pancreatic ATP-Sensitive Potassium Channel. | 2020 Jan 14 |
2 |
| 19 |
31567175 | Insulin Therapy in Type 2 Diabetes. | 2020 Jan/Feb |
1 |
| 20 |
31884929 | Mechanisms and Characteristics of Sulfonylureas and Glinides. | 2020 |
4 |
| 21 |
31956961 | Study Protocol for Pleiotropic Effects and Safety of Sodium-Glucose Cotransporter 2 Inhibitor Versus Sulfonylurea in Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease. | 2020 Feb |
1 |
| 22 |
32001615 | Homozygous Hypomorphic HNF1A Alleles Are a Novel Cause of Young-Onset Diabetes and Result in Sulfonylurea-Sensitive Diabetes. | 2020 Apr |
1 |
| 23 |
32201446 | Fasting insulin levels correlate with the frequency of hypoglycemic events in people with type 2 diabetes on treatment with sulfonylureas: A pilot study. | 2020 Jan-Feb |
4 |
| 24 |
32356495 | Emerging technologies in pediatrics: the paradigm of neonatal diabetes mellitus. | 2020 Dec |
1 |
| 25 |
32518064 | GIP and GLP-1 Potentiate Sulfonylurea-Induced Insulin Secretion in Hepatocyte Nuclear Factor 1α Mutation Carriers. | 2020 Sep |
2 |
| 26 |
32598150 | Structural Determinants of Insulin Release: Disordered N-Terminal Tail of Kir6.2 Affects Potassium Channel Dynamics through Interactions with Sulfonylurea Binding Region in a SUR1 Partner. | 2020 Jul 23 |
1 |
| 27 |
32656029 | Sulfonylurea-Induced Hypoglycemia in a Patient With Cirrhosis. | 2020 Jun 8 |
1 |
| 28 |
32728893 | Severe hypoglycaemia and absolute risk of cause-specific mortality in individuals with type 2 diabetes: a UK primary care observational study. | 2020 Oct |
2 |
| 29 |
32802709 | Efficacy and safety of a combination of an insulin secretagogue and a dipeptidyl peptidase-4 inhibitor in Japanese patients with type 2 diabetes mellitus; the repaglinide glucose oscillation study in Fukuoka (REGO-F). | 2020 Jul |
1 |
| 30 |
33102403 | Neonatal Diabetes Mellitus. | 2020 |
1 |
| 31 |
30242599 | MIR4532 gene variant rs60432575 influences the expression of KCNJ11 and the sulfonylureas-stimulated insulin secretion. | 2019 Mar |
3 |
| 32 |
30465123 | Body Weight Considerations in the Management of Type 2 Diabetes. | 2019 Jan |
1 |
| 33 |
30689785 | Central Mechanisms of Glucose Sensing and Counterregulation in Defense of Hypoglycemia. | 2019 Jun 1 |
1 |
| 34 |
30800266 | Diabetes: the place of new therapies. | 2019 |
1 |
| 35 |
31059802 | A benefit-harm analysis of adding basal insulin vs. sulfonylurea to metformin to manage type II diabetes mellitus in people with multiple chronic conditions. | 2019 Sep |
1 |
| 36 |
31196892 | Neonatal diabetes mellitus due to a novel variant in the INS gene. | 2019 Aug |
2 |
| 37 |
31231590 | The influence of SLC22A1 rs622342 and ABCC8 rs757110 genetic variants on the efficacy of metformin and glimepiride combination therapy in Egyptian patients with type 2 diabetes. | 2019 |
1 |
| 38 |
31237133 | Effectiveness and Safety of Adding Basal Insulin Glargine in Patients with Type 2 Diabetes Mellitus Exhibiting Inadequate Response to Metformin and DPP-4 Inhibitors with or without Sulfonylurea. | 2019 Aug |
1 |
| 39 |
31326458 | A comparison study on efficacy, insulin sensitivity and safety of Glimepiride/Metformin fixed dose combination versus glimepiride single therapy on type 2 diabetes mellitus patients with basal insulin therapy. | 2019 Sep |
1 |
| 40 |
31336501 | A systematic review on efficacy and safety of the current hypoglycemic agents in patients with diabetes during Ramadan fasting. | 2019 Mar - Apr |
1 |
| 41 |
31366755 | [Successful treatment of severe sulfonylurea-induced hypoglycemia by the subcutaneous administration of octreotide in an elderly patient with diabetes: A case report]. | 2019 |
1 |
| 42 |
31649868 | Conventional antidiabetic agents and bone health: A pilot case-control study. | 2019 Oct-Dec |
1 |
| 43 |
31828167 | Monotherapy with Metformin versus Sulfonylureas and Risk of Cancer in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis. | 2019 |
1 |
| 44 |
31908791 | Patterns of postmeal insulin secretion in individuals with sulfonylurea-treated KCNJ11 neonatal diabetes show predominance of non-KATP-channel pathways. | 2019 |
3 |
| 45 |
29278452 | Sulfonylurea vs insulin therapy in individuals with sulfonylurea-sensitive permanent neonatal diabetes mellitus, attributable to a KCNJ11 mutation, and poor glycaemic control. | 2018 Mar |
1 |
| 46 |
29305569 | Emergence of insulin resistance following empirical glibenclamide therapy: a case report of neonatal diabetes with a recessive INS gene mutation. | 2018 Mar 28 |
1 |
| 47 |
29675256 | A case with relapsed transient neonatal diabetes mellitus treated with sulfonylurea, ending chronic insulin requirement. | 2018 |
3 |
| 48 |
29681852 | Genotypic and Phenotypic Factors Influencing Drug Response in Mexican Patients With Type 2 Diabetes Mellitus. | 2018 |
1 |
| 49 |
29805453 | Factitious Hypoglycemia Caused by a Unique Pattern of Drug Use: A Case Report. | 2018 Jan |
1 |
| 50 |
29896782 | Permanent neonatal diabetes: combining sulfonylureas with insulin may be an effective treatment. | 2018 Jun 13 |
1 |